The Duration of Stone Disease and the Impact of a Stone Event on Patients' Quality of Life

被引:7
作者
Raizenne, Brendan L. [1 ]
Deyirmendjian, Claudia [2 ]
Bechis, Seth K. [3 ]
Sur, Roger L. [3 ]
Nakada, Stephen Y. [4 ]
Antonelli, Jodi A. [5 ]
Streeper, Necole M. [6 ]
Sivalingam, Sri [7 ]
Viprakasit, Davis P. [8 ]
Averch, Timothy D. [9 ]
Landman, Jaime [10 ]
Chi, Thomas [11 ]
Pais, Vernon M., Jr. [12 ]
Chew, Ben H. [13 ]
Bird, Vincent G. [14 ]
Andonian, Sero [15 ]
Canvasser, Noah E. [16 ]
Harper, Jonathan D. [17 ]
Penniston, Kristina L. [4 ]
Bhojani, Naeem [1 ]
机构
[1] Ctr Hosp Univ Montreal, Div Urol, Montreal, PQ, Canada
[2] Univ Montreal, Fac Med, Montreal, PQ, Canada
[3] Univ Calif San Diego, Dept Urol, San Diego, CA USA
[4] Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI USA
[5] Univ Texas Southwestern Med Ctr, Dept Urol, Dallas, TX USA
[6] Penn State Univ, Div Urol, Coll Med, Hershey, PA USA
[7] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[8] Univ N Carolina, Sch Med, Dept Urol, Chapel Hill, NC USA
[9] Palmetto Hlth Usc Med Grp, Dept Urol, Columbia, SC USA
[10] Univ Calif Irvine, Sch Med, Orange, CA USA
[11] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA
[12] Dartmouth Hitchcock Med Ctr, Urol Sect, Lebanon, NH USA
[13] Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada
[14] Univ Florida, Dept Urol, Coll Med, Gainesville, FL USA
[15] McGill Univ, Div Urol, Hlth Ctr, Montreal, PQ, Canada
[16] Univ Calif Davis, Dept Urol, Sacramento, CA USA
[17] Univ Washington, Dept Urol, Washington, DC USA
关键词
endourology; quality of life; kidney stone; HEALTH; NEPHROLITHIASIS;
D O I
10.1089/end.2021.0897
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: With a 5-year stone recurrence rate of 30% to 50%, kidney stone formers are subject to significant morbidity that negatively impacts their health-related quality of life (HRQOL). We sought to determine the impact of age at kidney stone onset, duration of stone disease, and kidney stone event (surgery or stone passage) on HRQOL of individual patients by querying the validated and prospectively collected Wisconsin Stone Quality of Life (WISQOL) database. Patients and Methods: Cross-sectional data were obtained from a total of 2438 kidney stone formers from 14 institutions in North America who completed the WISQOL questionnaire during the period from 2014 to 2019. The 28-question survey has a 1- to 5-point scale for each item (total score range 0-140). Multivariable linear regression models assessed the impact of age at kidney stone onset, duration of stone disease, and time since most recent surgery or stone passage on HRQOL. Results: Of 2438 patients, older age at kidney stone onset and longer duration of disease were both independent predictors of better WISQOL scores (beta = 0.33 points/year; confidence interval [CI] 0.17-0.49; p < 0.001; and beta = 0.50 points/year; CI 0.32-0.68; p < 0.001, respectively). Of 1376 patients who underwent surgery between 2010 and 2019, longer time since most recent surgery was an independent predictor of better WISQOL scores (beta = 2.28 points/year; CI: 1.47-3.10; p=< 0.001). Of 1027 patients with spontaneous stone passage occurring between 2010 and 2019, longer time since most recent stone passage was an independent predictor of better WISQOL scores (beta = 1.59 points/year; CI: 0.59-2.59; p=< 0.05). Conclusions: Our study demonstrates that older age at onset, longer duration of disease, and longer time since most recent surgery or stone passage were independent predictors of better HRQOL in kidney stone formers. Results of future studies that focus on optimizing stone-related modifiable risk factors to decrease the number of recurrent stone episodes and thus the need for recurrent surgeries will be essential.
引用
收藏
页码:1371 / 1376
页数:6
相关论文
共 50 条
  • [41] The Impact of Stone Multiplicity on Surgical Decisions for Patients with Large Stone Burden: Results from ReSKU
    Zetumer, Samuel
    Wiener, Scott
    Bayne, David B.
    Armas-Phan, Manuel
    Washington, Samuel L., III
    Tzou, David T.
    Stoller, Marshall
    Chi, Thomas
    JOURNAL OF ENDOUROLOGY, 2019, 33 (09) : 742 - 749
  • [42] Accurate stone analysis: the impact on disease diagnosis and treatment
    Mandel, Neil S.
    Mandel, Ian C.
    Kolbach-Mandel, Ann M.
    UROLITHIASIS, 2017, 45 (01) : 3 - 9
  • [43] Comparison of Empiric Preventative Pharmacologic Therapies on Stone Recurrence Among Patients with Kidney Stone Disease
    Hsi, Ryan S.
    Yan, Phyllis L.
    Crivelli, Joseph J.
    Goldfarb, David S.
    Shahinian, Vahakn
    Hollingsworth, John M.
    UROLOGY, 2022, 166 : 111 - 117
  • [44] Urinary stone disease in pediatric and adult metabolic bone clinic patients
    Schwaderer, Andrew L.
    Oduguwa, Abimbola
    Kusumi, Kirsten
    UROLITHIASIS, 2018, 46 (02) : 173 - 178
  • [45] Renal Stone Disease
    Sayer, John A.
    NEPHRON PHYSIOLOGY, 2011, 118 (01): : P35 - P44
  • [46] The economics of stone disease
    Noah E. Canvasser
    Peter Alken
    Michael Lipkin
    Stephen Y. Nakada
    Hiren S. Sodha
    Abdulkadir Tepeler
    Yair Lotan
    World Journal of Urology, 2017, 35 : 1321 - 1329
  • [47] Pathogenesis of Stone Disease
    Worcester, Elaine M.
    Evan, Andrew P.
    Coe, Fredric L.
    RENAL STONE DISEASE 2, 2008, 1049 : 3 - +
  • [48] Translation and validation of the Chinese version of Wisconsin Stone Quality of Life questionnaire in patients with kidney stones
    Zhong, Wen
    Xu, Jiandong
    Mazzon, Giorgio
    Zheng, Zexian
    Maolei, Yafang
    LI, Zhifeng
    Zeng, Guohua
    MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (03): : 353 - 358
  • [49] The economics of stone disease
    Canvasser, Noah E.
    Alken, Peter
    Lipkin, Michael
    Nakada, Stephen Y.
    Sodha, Hiren S.
    Tepeler, Abdulkadir
    Lotan, Yair
    WORLD JOURNAL OF UROLOGY, 2017, 35 (09) : 1321 - 1329
  • [50] Immunotherapy for stone disease
    Dominguez-Gutierrez, Paul R.
    Kwenda, Elizabeth P.
    Khan, Saeed R.
    Canales, Benjamin K.
    CURRENT OPINION IN UROLOGY, 2020, 30 (02) : 183 - 189